Skye Bioscience logo

Skye Bioscience

Skye Bioscience (OTC: SKYE) is a biopharmaceutical company engineering proprietary cannabinoid derivatives to treat glaucoma and other diseases with significant unmet medical needs.

Industries

Employees

11-50

Links


Org chart

Collapse

Board & advisors


Teams


Offices